A College of Veterinary Medicine research trial testing a new drug resulted in improved survival rates for dogs diagnosed with hemangiosarcoma.
The college hosted the Ninth International Conference on Canine and Feline Genetics and Genomics at the Landmark Center in St. Paul in May.
